ArticleCell death & disease2024

Therapeutic targeting of ARID1A-deficient cancer cells with RITA (Reactivating p53 and inducing tumor apoptosis).

Zihuan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.